封面
市場調查報告書
商品編碼
1672795

全球去礦物質骨基質(DBM) 市場按產品類型、組織來源、應用、最終用戶和地區分類

Demineralized Bone Matrix Market, By Product Type, By Tissue Source, By Application, By End User, By Geography

出版日期: | 出版商: Coherent Market Insights | 英文 172 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

2025 年全球去礦物質骨基質(DBM) 市場規模估計為 15 億美元,預計到 2032 年將達到 23.2 億美元,2025 年至 2032 年的複合年成長率為 6.4%。

報告範圍 報告詳細資訊
基準年 2024 2025 年市場規模 15億美元
效能資料 2020-2024 預測期 2025-2032
預測期:2025-2032年複合年成長率: 6.40% 2032 年價值預測 23.2億美元
數字。去礦物質骨基質(DBM)市場佔有率(%),按地區分類,2025 年
去礦骨基質市場-IMG1

過去幾年,全球去礦物質骨基質(DBM) 市場一直穩定成長。去礦物質骨基質(DBM) 是一種由同種異體骨去除骨中的礦物質成分後製成的骨生物材料。它可刺激骨骼形成,因此被用作牙科和整形外科手術中的骨移植替代品。由於創傷、骨折和各種骨骼相關疾病的發生率不斷增加,牙科和整形外科手術的數量不斷增加,是推動全球對去礦物質骨基質(DBM) 需求的因素之一。此外,人們越來越意識到 DBM 相對於自體骨移植的優勢,例如降低供體部位發病率和易於獲得,這進一步推動了市場的成長。然而,有關骨移植替代品核准的嚴格規定可能會在一定程度上限制市場。

市場動態:

推動全球去礦物質骨基質(DBM) 市場成長的關鍵因素包括易患骨病變的老年人口增加、牙科疾病盛行率上升、脊椎融合手術和重組手術增加,以及 DBM 相對於傳統骨移植的優勢。此外,透過各種技術增強 DBM 的骨誘導特性的持續研究和開發也為市場相關人員創造了新的機會。然而,對骨移植替代品核准的嚴格法律規範和與 DBM 產品相關的高成本是阻礙市場成長的主要挑戰。此外,對合成骨移植等骨移植替代品的偏好也在一定程度上限制了市場的擴張。

該研究的主要亮點:

本研究報告對全球去礦物質骨基質(DBM) 市場進行了詳細分析,並以 2024 年為基準年,給出了預測期 (2025-2032) 的市場規模和復合年成長率。

它揭示了各個領域的潛在商機並解釋了該市場的有吸引力的投資提案矩陣。

它還提供了關於市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域主要考察以及美敦力、萊特醫療集團、史賽克、強生(DePuy Synthes)、Zimmer Biomet、Xtant Medical 和 Hans Biomed 等主要企業採用的競爭策略的重要考慮因素。

本報告的見解將使負責人和公司經營團隊能夠就未來的產品發布、類型升級、市場擴張和行銷策略做出明智的決策。

本研究報告針對該產業的各個相關人員,包括投資者、供應商、產品製造商、經銷商、新進業者和財務分析師。

相關人員將透過用於分析全球去礦物質骨基質(DBM) 市場的各種策略矩陣來做出決策。

目錄

第1章 調查目的與前提條件

  • 研究目標
  • 先決條件
  • 簡稱

第2章 市場展望

  • 報告描述
    • 市場定義和範圍
  • 執行摘要

第3章市場動態、法規與趨勢分析

  • 市場動態
  • 影響分析
  • 主要亮點
  • 監管情景
  • 產品發布/核准
  • PEST分析
  • 波特的分析
  • 併購情景

4. 全球去礦物質骨基質(DBM) 市場依產品類型分類(2025-2032 年)

  • 油灰
  • 凝膠
  • 貼上
  • 條狀/片狀
  • 其他(插頭、光纖等)

5. 全球去礦物質骨基質(DBM) 市場依組織來源分類(2025-2032 年)

  • 同種異體移植
  • 異種移植

6. 全球去礦物質骨基質(DBM) 市場應用(2025-2032)

  • 脊椎融合手術
  • 創傷
  • 腳和腳踝
  • 牙科
  • 其他用途

7. 全球去礦物質骨基質(DBM) 市場依最終用戶分類(2025-2032 年)

  • 醫院
  • 整形外科門診
  • 學術研究所
  • 門診手術中心
  • 其他

8. 全球去礦物質骨基質(DBM) 市場按地區分類(2020-2032 年)

  • 北美洲
  • 美國
  • 加拿大
  • 拉丁美洲
  • 巴西
  • 阿根廷
  • 墨西哥
  • 其他拉丁美洲國家
  • 歐洲
  • 德國
  • 英國
  • 西班牙
  • 法國
  • 義大利
  • 俄羅斯
  • 其他歐洲國家
  • 亞太地區
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國
  • ASEAN
  • 其他亞太地區
  • 中東
  • 海灣合作理事會國家
  • 以色列
  • 其他中東地區
  • 非洲
  • 南非
  • 北非
  • 中部非洲

第9章 競爭格局

  • Medtronic plc
  • Johnson & Johnson(DePuy Synthes)
  • Zimmer Biomet
  • Stryker
  • SeaSpine
  • Xtant Medical
  • RTI Surgical
  • HansBioMed
  • Arthrex GmbH
  • Exactech, Inc.
  • AlloSource
  • Halma(Novabone)
  • Institut Straumann AG
  • Orthofix Holdings, Inc.
  • Straumann
  • Synthes
  • Integra LifeSciences
  • Musculoskeletal Transplant Foundation(MTF)
  • Bacterin International
  • Osiris Therapeutics

第 10 章分析師建議

  • 命運之輪
  • 分析師觀點
  • Coherent Opportunity Map(COM)

第 11 章 參考文獻與調查方法

  • 參考
  • 調查方法
  • 關於出版商
簡介目錄
Product Code: CMI4550

Global Demineralized Bone Matrix Market is estimated to be valued at USD 1.50 Bn in 2025 and is expected to reach USD 2.32 Bn by 2032, growing at a compound annual growth rate (CAGR) of 6.4% from 2025 to 2032.

Report Coverage Report Details
Base Year: 2024 Market Size in 2025: USD 1.50 Bn
Historical Data for: 2020 To 2024 Forecast Period: 2025 To 2032
Forecast Period 2025 to 2032 CAGR: 6.40% 2032 Value Projection: USD 2.32 Bn
Figure. Demineralized Bone Matrix Market Share (%), By Region 2025
Demineralized Bone Matrix Market - IMG1

The global demineralized bone matrix market has been growing steadily over the past few years. Demineralized bone matrix (DBM) is an osteobiologic material made from allogeneic bone after removing mineral components from the bone. It is utilized as a bone graft substitute in dental and orthopaedic procedures to stimulate bone formation. Rising number of dental surgeries and orthopaedic procedures due to increasing incidence of trauma injuries, bone fractures and various bone related diseases are some of the factors fueling demand for demineralized bone matrix globally. Moreover, growing awareness about advantages of DBM over autografts such as reduced donor site morbidity and greater availability is further supplementing the market growth. However, stringent regulations for approval of bone graft substitutes may restrain the market to a certain extent.

(Market Dynamics):

The key drivers propelling the growth of the global demineralized bone matrix market include rising geriatric population susceptible to bone disorders, increasing prevalence of dental diseases, growing number of spinal fusion and reconstruction surgeries, and advantages offered by DBM over conventional bone grafts. Additionally, ongoing research and development activities focused on enhancing osteoinductive properties of DBM through various techniques are creating new opportunities for market players. However, stringent regulatory framework for approval of bone graft substitutes and high costs associated with DBM products are some of the major challenges hampering the market growth. Moreover, preference for alternative bone grafting materials such as synthetic bone grafts is also restricting the market expansion to some extent.

(Key features of the study):

This report provides in-depth analysis of the global demineralized bone matrix market, and provides market size (USD billion) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year

It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market

This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players such as Medtronic, Wright Medical Group, Stryker, J &J (DePuy Synthes), Zimmer Biomet, Xtant Medical, and Hans Biomed

Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics

The global demineralized bone matrix market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global demineralized bone matrix market.

Detailed Segmentation:

  • Product Type Insights (Revenue, USD Bn, 2020 - 2032)
    • Putty
    • Gel
    • Paste
    • Strips/Sheets
    • Others (Plugs, Fibers, etc.)
  • Tissue Source Insights (Revenue, USD Bn, 2020 - 2032)
    • Allograft
    • Xenograft
  • Application Insights (Revenue, USD Bn, 2020 - 2032)
    • Spinal Fusion
    • Trauma
    • Foot and Ankle
    • Dental
    • Other Applications
  • End user Insights (Revenue, USD Bn, 2020 - 2032)
    • Hospitals
    • Orthopedic Clinics
    • Academic and Research Institutes
    • Ambulatory Surgical Centers
    • Others
  • Regional Insights (Revenue, USD Bn, 2020 - 2032)
    • North America
    • U.S.
    • Canada
    • Latin America
    • Brazil
    • Argentina
    • Mexico
    • Rest of Latin America
    • Europe
    • Germany
    • U.K.
    • Spain
    • France
    • Italy
    • Russia
    • Rest of Europe
    • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
    • Middle East
    • GCC Countries
    • Israel
    • Rest of Middle East
    • Africa
    • South Africa
    • North Africa
    • Central Africa
  • Key Players Insights
    • Medtronic plc
    • Johnson & Johnson (DePuy Synthes)
    • Zimmer Biomet
    • Stryker
    • SeaSpine
    • Xtant Medical
    • RTI Surgical
    • HansBioMed
    • Arthrex GmbH
    • Exactech, Inc.
    • AlloSource
    • Halma (Novabone)
    • Institut Straumann AG
    • Orthofix Holdings, Inc.
    • Straumann
    • Synthes
    • Integra LifeSciences
    • Musculoskeletal Transplant Foundation (MTF)
    • Bacterin International
    • Osiris Therapeutics

Table of Contents

1. RESEARCH OBJECTIVES AND ASSUMPTIONS

  • Research Objectives
  • Assumptions
  • Abbreviations

2. MARKET PURVIEW

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Global Demineralized Bone Matrix Market, By Product Type
    • Global Demineralized Bone Matrix Market, By Tissue Source
    • Global Demineralized Bone Matrix Market, By Application
    • Global Demineralized Bone Matrix Market, By End User
    • Global Demineralized Bone Matrix Market, By Region

3. MARKET DYNAMICS, REGULATIONS, AND TRENDS ANALYSIS

  • Market Dynamics
  • Impact Analysis
  • Key Highlights
  • Regulatory Scenario
  • Product Launches/Approvals
  • PEST Analysis
  • PORTER's Analysis
  • Merger and Acquisition Scenario

4. Global Demineralized Bone Matrix Market, By Product Type, 2025-2032, (USD Bn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Putty
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Gel
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Paste
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Strips/Sheets
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Others (Plugs, Fibers, etc.)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

5. Global Demineralized Bone Matrix Market, By Tissue Source, 2025-2032, (USD Bn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2020 - 2032
    • Segment Trends
  • Allograft
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Xenograft
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

6. Global Demineralized Bone Matrix Market, By Application, 2025-2032, (USD Bn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2020 - 2032
    • Segment Trends
  • Spinal Fusion
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Trauma
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Foot and Ankle
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Dental
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Other Applications
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

7. Global Demineralized Bone Matrix Market, By End-User, 2025-2032, (USD Bn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2020 - 2032
    • Segment Trends
  • Hospitals
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Orthopedic Clinics
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Academic and Research Institutes
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Ambulatory Surgical Centers
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

8. Global Demineralized Bone Matrix Market, By Region, 2020 - 2032, Value (USD Bn)

  • Introduction
    • Market Share (%) Analysis, 2025,2028 & 2032, Value (USD Bn)
    • Market Y-o-Y Growth Analysis (%), 2020 - 2032, Value (USD Bn)
    • Regional Trends
  • North America
    • Introduction
    • Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Tissue Source, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By End-User, 2020 - 2032, Value (USD Bn)
  • U.S.
  • Canada
  • Latin America
    • Introduction
    • Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Tissue Source, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By End-User, 2020 - 2032, Value (USD Bn)
  • Brazil
  • Argentina
  • Mexico
  • Rest of Latin America
  • Europe
    • Introduction
    • Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Tissue Source, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By End-User, 2020 - 2032, Value (USD Bn)
  • Germany
  • U.K.
  • Spain
  • France
  • Italy
  • Russia
  • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Tissue Source, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By End-User, 2020 - 2032, Value (USD Bn)
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • ASEAN
  • Rest of Asia Pacific
  • Middle East
    • Introduction
    • Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Tissue Source, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By End-User, 2020 - 2032, Value (USD Bn)
  • GCC Countries
  • Israel
  • Rest of Middle East
  • Africa
    • Introduction
    • Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Tissue Source, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By End-User, 2020 - 2032, Value (USD Bn)
  • South Africa
  • North Africa
  • Central Africa

9. COMPETITIVE LANDSCAPE

  • Medtronic plc
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Johnson & Johnson (DePuy Synthes)
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Zimmer Biomet
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Stryker
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • SeaSpine
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Xtant Medical
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • RTI Surgical
  • HansBioMed
  • Arthrex GmbH
  • Exactech, Inc.
  • AlloSource
  • Halma (Novabone)
  • Institut Straumann AG
  • Orthofix Holdings, Inc.
  • Straumann
  • Synthes
  • Integra LifeSciences
  • Musculoskeletal Transplant Foundation (MTF)
  • Bacterin International
  • Osiris Therapeutics

10. Analyst Recommendations

  • Wheel of Fortune
  • Analyst View
  • Coherent Opportunity Map

11. References and Research Methodology

  • References
  • Research Methodology
  • About us